Medications Categories - Best8-Weekfitness

Changes to Medi-Cal’s Troubled Drug Program Reduce Backlog in California, but Problems Persist

14/03/2022

SACRAMENTO, Calif. — The contractor running California’s new Medicaid prescription drug program has addressed shortfalls that earlier this year left thousands of enrollees without critical medications, some languishing on hold for hours as they sought help, state officials told lawmakers Thursday. But doctors and health care clinics say that some patients are still suffering and that the state and its contractor, […]

Colchones y remoción de moho: Medi-Cal ofrecerá tratamientos no tradicionales a personas con asma

10/01/2022

MADERA, California. – Al crecer en medio de los polvorientos campos agrícolas del Valle Central, Ruby Marentes-Cabrera no puede recordar un momento en el que no fuera difícil respirar. Diagnosticada con asma de pequeña, la estudiante de noveno grado ha llegado a detestar los árboles de pistacho que rodean su casa. El polvo, los pesticidas y otros alérgenos de las […]

Georgia Eyes New Medicaid Contract. But How Is the State Managing Managed Care?

13/09/2021

Just before Frank Berry left his job as head of Georgia’s Medicaid agency this summer, he said the state “will be looking for the best bang for the buck” in its upcoming contract with private insurers to cover the state’s most vulnerable. But whether the state — and Medicaid patients — are getting an optimal deal on Medicaid is up […]

FDA Approves Skytrofa

26/08/2021

FDA Approves Skytrofa (lonapegsomatropin-tcgd) for the Once-Weekly Treatment of Pediatric Growth Hormone Deficiency COPENHAGEN, Denmark, Aug. 25, 2021 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon technologies to potentially create new treatments that make a meaningful difference in patients’ lives, today announced that the U.S. Food and Drug Administration (FDA) has approved […]

FDA Approves Expanded Botox (onabotulinumtoxinA) Label to Include Eight New Muscles to Treat Adults with Upper Limb Spasticity

02/08/2021

NORTH CHICAGO, Ill., July 29, 2021 /PRNewswire/ — Allergan, an AbbVie (NYSE: ABBV) company, today announced that the U.S. Food and Drug Administration (FDA) has approved a label expansion of Botox® to include eight new muscles for the treatment of upper limb spasticity in adults. The new muscles for treatment include additional muscles of the elbow and forearm (brachialis, brachioradialis, […]

Journalists Track Biden’s First 100 Days

01/05/2021

Chief Washington correspondent Julie Rovner discussed Biden’s first 100 days on WAMU/NPR’s “1A” on Wednesday. She also joined Wisconsin Public Radio’s “Central Time” to talk about why hospitals aren’t cooperating with price transparency requirements. Click here to hear Rovner on WAMU/NPR Read Rovner’s “The Great Undoing: Which of Trump’s Policies Will Biden Reverse?” Click here to hear Rovner on Wisconsin […]

Scientists Seek Covid Treatment Answers in Cheap, Older Drugs

02/04/2021

Could a decades-old antidepressant be a secret weapon against covid? A few scientists think so, after two small studies showed that fluvoxamine, typically prescribed for obsessive-compulsive disorder, prevented serious illness in all participants who took the pills soon after developing symptoms. It’s an exciting notion: A $10, two-week course of this drug could reduce death and hospitalizations. The drug could […]

FDA Approves Ponvory

20/03/2021

FDA Approves Ponvory (ponesimod) for the Treatment of Adults with Relapsing Multiple Sclerosis TITUSVILLE, N.J. – (March 19, 2021) – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) approved Ponvory™ (ponesimod), a once-daily oral selective sphingosine-1-phosphate receptor 1 (S1P1) modulator, to treat adults with relapsing forms of multiple sclerosis (MS), […]

Micardis® (Telmisartan) Consumer Medicine Information

02/02/2021

Micardis® Tablets Telmisartan Consumer Medicine Information NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. This page contains answers to some common questions about Micardis®. It does not contain all the information that is known about Micardis®. It does not take the place of talking to your doctor or pharmacist. All medicines have […]

APOTEX-Pioglitazone

01/02/2021

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. APOTEX-PIOGLITAZONE Pioglitazone hydrochloride Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about pioglitazone. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your […]

1 2 3 … 13 »